SCM
SPRB

Superstring Capital Management’s Spruce Biosciences SPRB Stock Holding History

Superstring Capital Management’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,137
Closed -$1.06M – 59
2025
Q4 		$1.06M Buy
+12,137
New +$1.3M 0.57% 35
2024
Q3 		– Sell
-1,040
Closed -$40.4K – 46
2024
Q2 		$40.4K Sell
1,040
-4,830
-82% -$259K 0.05% 39
2024
Q1 		$346K Buy
5,870
+4,286
+271% +$1.09M 0.23% 35
2023
Q4 		$348K Buy
+1,584
New +$183K 0.25% 29

Other funds holding SPRB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Superstring Capital Management's SPRB Position: Q1 2026 in Review

Superstring Capital Management sold out of Spruce Biosciences (SPRB) in Q1 2026, closing a stake of 12,137 shares — an estimated $1.06M sold.

Superstring Capital Management first reported a position in SPRB in Q4 2023 and held it in 4 quarters. The position peaked at $1.06M in Q4 2025. 32 funds tracked by Wall St. Rank hold SPRB as of Q1 2026.

  • Superstring Capital Management reported no remaining Spruce Biosciences position as of Q1 2026 after selling out during the quarter.
  • Superstring Capital Management sold 12,137 Spruce Biosciences shares in Q1 2026, an estimated $1.06M.
  • Superstring Capital Management first reported a position in Spruce Biosciences in Q4 2023 and held it in 4 quarters.
  • Superstring Capital Management's Spruce Biosciences position peaked at $1.06M in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Spruce Biosciences as of Q1 2026.

Based on Superstring Capital Management's 13F filing for Q1 2026, filed 14 May 2026.